1. Home
  2. BRCC vs KZIA Comparison

BRCC vs KZIA Comparison

Compare BRCC & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRC Inc.

BRCC

BRC Inc.

HOLD

Current Price

$1.24

Market Cap

186.6M

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$11.09

Market Cap

161.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRCC
KZIA
Founded
2014
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.6M
161.5M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
BRCC
KZIA
Price
$1.24
$11.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$2.63
$17.67
AVG Volume (30 Days)
535.6K
2.0M
Earning Date
11-03-2025
12-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$391,401,000.00
$1,199,108.00
Revenue This Year
$3.12
N/A
Revenue Next Year
$11.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$2.86
52 Week High
$3.34
$21.00

Technical Indicators

Market Signals
Indicator
BRCC
KZIA
Relative Strength Index (RSI) 45.95 51.53
Support Level $1.22 $11.75
Resistance Level $1.28 $17.40
Average True Range (ATR) 0.05 2.71
MACD 0.01 0.07
Stochastic Oscillator 43.33 35.08

Price Performance

Historical Comparison
BRCC
KZIA

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: